Skip to content
10-Q

Quarterly Report

REGENEREX PHARMA, INC. RGPX

0001472375-23-000142

← back to feed
Filed
Nov 8, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2023 · Nov 8, 2023 277.92M sh
Cash And Equivalents Q2 2023 · Sep 30, 2023 $6.08K
Cash And Equivalents Q2 2023 · Mar 31, 2023 $1.14K
Current Liabilities Q2 2023 · Sep 30, 2023 $3.34M
Current Liabilities Q2 2023 · Mar 31, 2023 $776.78K
Total Liabilities Q2 2023 · Sep 30, 2023 $4.57M
Total Liabilities Q2 2023 · Mar 31, 2023 $1.13M
Current Assets Q2 2023 · Sep 30, 2023 $19.33K
Current Assets Q2 2023 · Mar 31, 2023 $1.14K
Total Assets Q2 2023 · Sep 30, 2023 $932.64K
Total Assets Q2 2023 · Mar 31, 2023 $6.54K
Operating Cash Flow Q2 2023 · Sep 30, 2022 −$44.51K
Stockholders Equity Q2 2023 · Sep 30, 2022 −$1.03M
Stockholders Equity Q2 2023 · Jun 30, 2022 −$1.01M
Stockholders Equity Q2 2023 · Mar 31, 2022 −$985.62K
Net Income Q2 2023 · Sep 30, 2022 −$18.44K
Net Income Q2 2023 · Sep 30, 2022 −$41.64K
Net Income Q2 2023 · Jun 30, 2022 −$23.2K
Operating Income Q2 2023 · Sep 30, 2022 −$21.5K
Operating Income Q2 2023 · Sep 30, 2022 −$38.79K